Q2 2018 Holdings
Filed 2018-08-13 | 75 holdings | $28.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.5M | 315,345 | 30.5% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $6.1M | 610,738 | 21.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $4.9M | 73,745 | 17.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.5M | 604,652 | 12.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.2M | 25,949 | 7.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.8M | 472,859 | 6.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $576.0K | 69,437 | 2.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $307.0K | 2,000 | 1.1% |
| Loxo Oncology Inc | COM | 548862101 | $27.5K | 158,675 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $15.0K | 96,000 | 0.1% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $10.5K | 13,680,554 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $8.9K | 131,770 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $8.5K | 306,119 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $6.3K | 396,013 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $5.9K | 92,691 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.2K | 55,000 | 0.0% |
| Luminex Corp | COM | 55027E102 | $5.0K | 169,891 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.5K | 45,508 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.4K | 239,500 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.3K | 183,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $4.3K | 97,764 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $4.2K | 95,242 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.0K | 294,511 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.7K | 40,609 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.7K | $4,000,000 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $2.9K | 26,100 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.7K | 294,362 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $2.7K | 947,636 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $2.6K | 934,691 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $2.5K | 312,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $2.5K | 568,600 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.5K | 54,500 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $2.4K | $2,500,000 | 0.0% |
| Scynexis Inc | COM | 811292101 | $2.1K | 1,275,527 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $1.9K | 59,200 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.8K | 47,900 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.7K | 338,000 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $1.7K | 163,377 | 0.0% |
| Insulet Corp | NOTE 1.375% | 45784PAG6 | $1.7K | $1,500,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.6K | 78,305 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $1.6K | 421,000 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $1.5K | 328,500 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $1.4K | 21,500 | 0.0% |
| Leap Therpeutics Inc | COM | 52187K101 | $1.4K | 151,643 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.3K | 110,000 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $1.3K | 37,900 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $1.3K | 171,351 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $1.2K | 62,811 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.1K | 9,400 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.1K | 212,766 | 0.0% |